Cloudbreak Pharma Inc. (Stock Code: 02592) Announces Monthly Return for February 2026

Bulletin Express03-02

Cloudbreak Pharma Inc. reported no changes in the total authorized share capital during February 2026, with 2,000,000,000 ordinary shares authorized at a par value of USD 0.0001 each, resulting in a total authorized capital of USD 200,000.

The issued shares remained at 850,122,081, with none held in treasury. The minimum public float threshold of 25% was satisfied at the end of the month.

No increase or decrease in share issuances or treasury shares was noted. The company’s equity incentive plans, including Series B, Series C, the 2023 Equity Incentive Scheme, and the Post-IPO Equity Incentive Scheme, indicated no new shares issued or transferred out of treasury, with available shares remaining unchanged.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165597787?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-02 15:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165597787","market":"hk","top_or_hot":-1,"title":"Cloudbreak Pharma Inc. (Stock Code: 02592) Announces Monthly Return for February 2026","media":"Bulletin Express","content":"<p>Cloudbreak Pharma Inc. reported no changes in the total authorized share capital during February 2026, with 2,000,000,000 ordinary shares authorized at a par value of USD 0.0001 each, resulting in a total authorized capital of USD 200,000.</p>\n<p>The issued shares remained at 850,122,081, with none held in treasury. The minimum public float threshold of 25% was satisfied at the end of the month.</p>\n<p>No increase or decrease in share issuances or treasury shares was noted. The company’s equity incentive plans, including Series B, Series C, the 2023 Equity Incentive Scheme, and the Post-IPO Equity Incentive Scheme, indicated no new shares issued or transferred out of treasury, with available shares remaining unchanged.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cloudbreak Pharma Inc. (Stock Code: 02592) Announces Monthly Return for February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCloudbreak Pharma Inc. (Stock Code: 02592) Announces Monthly Return for February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-02 15:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cloudbreak Pharma Inc. reported no changes in the total authorized share capital during February 2026, with 2,000,000,000 ordinary shares authorized at a par value of USD 0.0001 each, resulting in a total authorized capital of USD 200,000.</p>\n<p>The issued shares remained at 850,122,081, with none held in treasury. The minimum public float threshold of 25% was satisfied at the end of the month.</p>\n<p>No increase or decrease in share issuances or treasury shares was noted. The company’s equity incentive plans, including Series B, Series C, the 2023 Equity Incentive Scheme, and the Post-IPO Equity Incentive Scheme, indicated no new shares issued or transferred out of treasury, with available shares remaining unchanged.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02592","symbol_name":"拨康视云-B","start_time":0,"source_url":"","article_id":"1165597787","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165597787","pubTimestamp":1772435225,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Cloudbreak Pharma Inc. reported no changes in the total authorized share capital during February 2026, with 2,000,000,000 ordinary shares authorized at a par value of USD 0.0001 each, resulting in a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02592":"拨康视云-B"},"translate_title":"Cloudbreak Pharma Inc.(股份代号：02592)公布2026年2月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02592":1},"content_text":"Cloudbreak Pharma Inc. reported no changes in the total authorized share capital during February 2026, with 2,000,000,000 ordinary shares authorized at a par value of USD 0.0001 each, resulting in a total authorized capital of USD 200,000.\nThe issued shares remained at 850,122,081, with none held in treasury. The minimum public float threshold of 25% was satisfied at the end of the month.\nNo increase or decrease in share issuances or treasury shares was noted. The company’s equity incentive plans, including Series B, Series C, the 2023 Equity Incentive Scheme, and the Post-IPO Equity Incentive Scheme, indicated no new shares issued or transferred out of treasury, with available shares remaining unchanged.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165597787","isCrawlerRequest":true}